SCP Vitalife Partners (Israel) II, L.P., 10% Owner at Recro Pharma, Inc. (REPH), sold 37,660 shares at $3.17 ($119K) on 2020-12-22, disclosed to the SEC on 2020-12-28.
Open-market sale of $119k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.17 | 18,830 | $60K | 50.0% |
| 2 | $3.17 | 18,830 | $60K | 50.0% |
| Total | $3.17 avg | 37,660 | $119K | 100% |
| Filing → |
| REPH | SELL | 2018-01-04 | $230K | — | Filing → |
| REPH | SELL | 2018-01-02 | $56K | — | Filing → |
| REPH | SELL | 2017-12-28 | $42K | — | Filing → |